Projets financés
STROKE RISK PREDICTION IN ATHEROSCLEROSIS MEASURING CIRCULATING COMPLEMENT SYSTEM PROTEINS – STATEMENT
Neurovascular damage determines disease pathophysiology in pediatric mild traumatic brain injury: source of new biomarkers – Neu-vasc
Biomarkers of ANTidepressant RESponse : early indicators and novel targets – ANTaRES
A neurocomputational biomarker assay for schizophrenia based on E/I-balance – IMBALANCE
Metabolic profiling of the gut-brain axis as a new stratification process to improve behavioural disorders: proof of concept in alcohol dependence – GUT2BEHAVE
Multi-level integrative ‘omics to identify biomarkers in a Schizophrenia and other major psychoses – Muliobio
Neuroimaging and Blood Markers as Indicators of Ketamine Efficacy in Treatment Resistant Depression – NeuroMarKet
Genomic, epigenetic and proteomic biomarkers in psychosis: a translational approach including high-risk individuals, patients with schizophrenia and animal models – GEPI-BIOPSY
Altered Translation in Autism – ALTRUISM
